| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/21/2008 | WO2008006714A3 Improvements relating to biocidal compositions |
| 02/21/2008 | WO2008003329A3 Nanoparticles for nucleic acid delivery |
| 02/21/2008 | WO2008003327A3 Immunotoxins for the treatment of diseases related to cmv infection |
| 02/21/2008 | WO2008001240A3 Transdermal delivery of oleocanthal for relief of inflammation |
| 02/21/2008 | WO2007145919A3 Product and process for increasing compactibility of carbohydrates |
| 02/21/2008 | WO2007125545A3 Transmucosal composition |
| 02/21/2008 | WO2007119601A3 Nanoparticles comprising a pdgf receptor tyrosine kinase inhibitor |
| 02/21/2008 | WO2007109221A3 Methods for reducing protein aggregation |
| 02/21/2008 | WO2007086541A3 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound |
| 02/21/2008 | WO2007027560A8 Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents |
| 02/21/2008 | WO1999059544A9 Orally disintegrable tablets |
| 02/21/2008 | US20080045606 Production and Use of Monoglycerides |
| 02/21/2008 | US20080045553 Transdermal Administration of Phycotoxins |
| 02/21/2008 | US20080045546 Tetradydro-Naphthalene And Urea Derivatives |
| 02/21/2008 | US20080045477 Series Of New 4,6-Diamino-1,2-Dihydro-1-Aryl-1,3,5-Triazines, Substituted By An Adamantyl Moiety In The Position 2 Of Triazine-Their Corresponding Salts, Isomers,Steroisomers, Enantiomers, Free Bases And The Complexes Of All The Above With Natural Macromolecules And Their Synthetic Derivatives. |
| 02/21/2008 | US20080045444 Compositions and methods for treating cardiovascular disease and myocardial infarction with dipeptidyl peptidase inhibitors or b type natriuretic peptide analogues resistant to prolyl-specific dipeptidyl degradation |
| 02/21/2008 | US20080044840 Using transmembrane protein with EGF-like and 2 follistatin-like domains 2 (TMEFF2) specific immunogllobulin for diagnosis and treatment of prostate cancer |
| 02/21/2008 | US20080044485 increased viscosity of the injection vehicle that constitutes the fluid phase of the suspension significantly reduces in vivo injectability failures; microparticles; drugs such as risperidone |
| 02/21/2008 | US20080044478 Preparation of injectable suspensions having improved injectability |
| 02/21/2008 | US20080044476 Mixture of corticosteroid and sodium hyaluronate in aqueous carrier |
| 02/21/2008 | US20080044474 Dispersions of nanoureas comprising biologically active compounds |
| 02/21/2008 | US20080044472 Photoresponsive Hydrogels |
| 02/21/2008 | US20080044470 Pharmaceutical composition with controlled acitve ingredient release for active ingredients with good solubility in water |
| 02/21/2008 | US20080044469 Rapidly Dispersible, Fine-Particle Film-Coating Composition Which is in Powder Form, is not Prone to Segregation and is Baased on Polyvinyl Alcohol-Polyether Graft Copolymers Characterized by Particular Physical Stability and Low Asperity |
| 02/21/2008 | US20080044464 Liposome loading with metal ions |
| 02/21/2008 | US20080044455 Tonsillitus Treatment |
| 02/21/2008 | US20080044454 Protectively coated controlled release particles distributed throughout water soluble film delivery agent; easy oral delivery for patients having difficulty swallowing tablets |
| 02/21/2008 | US20080044386 Protamine-Adenoviral Vector Complexes and Methods of Use |
| 02/21/2008 | US20080044381 Stable liquid interferon formulations |
| 02/21/2008 | US20080044371 Taste-Masked Composition of Cationic Exchange Resin |
| 02/21/2008 | DE102004038131B4 Polymerisierbare oder vernetzbare Dotierstoffe, diese enthaltende flüssigkristalline Zusammensetzung und deren Verwendung Polymerizable or crosslinkable dopants containing these liquid crystalline composition and its use |
| 02/21/2008 | CA2678051A1 Peptides that target to tumor blood vessels of lung cancer and applications thereof |
| 02/21/2008 | CA2660488A1 Aerosol formulation for the inhalation of beta agonists |
| 02/21/2008 | CA2660289A1 Polymer particles including covalently bonded chemical species |
| 02/21/2008 | CA2659562A1 Stable lyophilized preparation |
| 02/21/2008 | CA2658474A1 A conjugate of an antibody against ccr5 and an antifusogenic peptide |
| 02/20/2008 | EP1889915A1 APO-2 ligand |
| 02/20/2008 | EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 02/20/2008 | EP1889628A1 Lipid liposome composition |
| 02/20/2008 | EP1889620A1 Eye drop containing roflumilast |
| 02/20/2008 | EP1889611A1 Sugar-coated tablet |
| 02/20/2008 | EP1889608A1 Therapeutic hydrogel for atopic dermatitis and preparation method thereof |
| 02/20/2008 | EP1889607A1 Injectable liquid paracetamol formulation |
| 02/20/2008 | EP1888651A1 Aldehyde conjugated flavonoid preparations |
| 02/20/2008 | EP1888645A2 Anti-cd16 binding molecules |
| 02/20/2008 | EP1888624A2 Method of purifying apo-2 ligand/trail using crystallisation in the cold |
| 02/20/2008 | EP1888510A2 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
| 02/20/2008 | EP1888491A1 Isoalkane mixture, its preparation and use |
| 02/20/2008 | EP1888131A2 Treatment and pre-treatment device, and manufacturing method therefor, involving nitric oxide |
| 02/20/2008 | EP1888124A1 Mri contrast medium containing liposomes |
| 02/20/2008 | EP1888122A2 A method for preparing a stable immunogenic product comprising antigenic heterocomplexes of tnf alpha and a carrier protein |
| 02/20/2008 | EP1888121A2 Anticancer targeted conjugates comprising a succinyl or glutaryl linker |
| 02/20/2008 | EP1888120A2 Novel salts of conjugated psychotropic drugs and processes of preparing same |
| 02/20/2008 | EP1888119A2 Pegylated g-csf polypeptides and methods of producing same |
| 02/20/2008 | EP1888118A1 Stabilized polypeptide formulations |
| 02/20/2008 | EP1888117A1 Stabilized polypeptide formulations |
| 02/20/2008 | EP1888069A2 New antiproliferative drug |
| 02/20/2008 | EP1888029A2 Topical ungual formulations |
| 02/20/2008 | EP1888027A1 Medicated product for local use based on natural materials |
| 02/20/2008 | EP1888025A2 Medicament carrier composition and method of forming a film therefrom |
| 02/20/2008 | EP1888024A1 Topical compositions |
| 02/20/2008 | EP1887864A1 Method and composition for use in preparation of a patient for surgery |
| 02/20/2008 | EP1603559B1 Pharmaceutical composition for intracellular acidification with cis-urocanic acid |
| 02/20/2008 | EP1581226B1 Inclusion complex of anti-tubercular rifampicin with beta-cyclodextrin or 2-hydroxypropyl beta-cyclodextrin and a process for producing the same |
| 02/20/2008 | EP1575600B1 Cosmetic preparations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride |
| 02/20/2008 | EP1465989B1 Growth factor modified protein matrices for tissue engineering |
| 02/20/2008 | EP1458389B1 Aqueous solutions of moxaverin for the treatment of erectile dysfunction |
| 02/20/2008 | EP1455832B1 Pulsed bio-agent delivery systems based on in vivo degradable and swellable modified dextran hydrogels |
| 02/20/2008 | EP1451242B1 Water-in-silicone emulsions |
| 02/20/2008 | EP1443964B1 Photodynamic therapy for the treatment of hair loss |
| 02/20/2008 | EP1427392B1 New self emulsifying drug delivery system |
| 02/20/2008 | EP1421092A4 Neutral glycosphingolipids and glycosyl-sphingosines and methods for isolating the same |
| 02/20/2008 | EP1414407B1 Dosage forms comprising particles containing active ingredient for application on the skin or mucous membrane |
| 02/20/2008 | EP1372637B1 Premixed amiodarone parenteral solution and method for making the same |
| 02/20/2008 | EP1285947B1 Antimicrobial composition |
| 02/20/2008 | EP1194170B1 Growth hormone formulations |
| 02/20/2008 | EP1154761B1 Solid oral dosage form containing an enhancer |
| 02/20/2008 | EP1101497B1 Stabilized oily preparations of tobicillin (beta-lactam antibiotic) |
| 02/20/2008 | EP1029537B1 Sustained release eyedrops |
| 02/20/2008 | EP0986309B1 Uses of oil bodies |
| 02/20/2008 | EP0918872B1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
| 02/20/2008 | EP0870500B1 Anti-helicobacter pylori agent |
| 02/20/2008 | CN101128487A Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY |
| 02/20/2008 | CN101128185A Aqueous topical gel of high stability based on metronidazole and method of preparation |
| 02/20/2008 | CN101128183A Composition containing chitosan for sustained drug release |
| 02/20/2008 | CN101125930A Light-sensitive microcapsule used for medicament transmission and release and preparation method thereof |
| 02/20/2008 | CN101125926A Terminal amido group start-type poly (lactic-co-glycolic acid)/polyglycol block copolymer, preparation method, medicament-carried nano micelle and application |
| 02/20/2008 | CN101125916A Biodegradation polymer and its preparing process and application |
| 02/20/2008 | CN101125207A Exendin or its analogs with polyethylene group and its preparation and application |
| 02/20/2008 | CN101125206A Diolpolymer-interleukin-1 receptor antagonists conjugate and preparation method and application |
| 02/20/2008 | CN101125205A Polyethylene decorative nevin fibrinolytic enzyme and its preparation method |
| 02/20/2008 | CN101125204A Solid dosage form comprising solid dispersion and method for producing the same |
| 02/20/2008 | CN101125187A Traditional Chinese medicinal plaster for treating pulmonary tuberculosis |
| 02/20/2008 | CN101125170A Gastric floating composition for sobering up |
| 02/20/2008 | CN101125161A Burn cream for treating burn and scald and its preparation method |
| 02/20/2008 | CN101125150A Application of nanometer zinc oxide in preparing medicine for treating malignant tumor |
| 02/20/2008 | CN101125147A Glucosamine calcium medicine preparation, preparation method and application thereof |
| 02/20/2008 | CN101125145A Local using prostaglandin micro emulsion and its preparation method |
| 02/20/2008 | CN101125137A Pharmaceutical salts |
| 02/20/2008 | CN101125134A Hydrochloric tamsulosin sustained-release capsule and its preparation method |